The meta-analysis for 2 studies, patients in 200 mg group had the percentage of reaching therapeutic range, 5 - 15 g / ml, so low, 26.3% compared to 79.5% in 400 mg group (p=0.0004), with relative risk ratio of 1, 8<3.6<7.3 (RR and 95% CI).